The effects of leisure-time physical activity (LTPA) on glycemia and cardiovascular risk factors are not fully understood in Asian type 2 diabetic patients, who are typically non-obese. We studied associations between LTPA and glycemia and cardiovascular risk factors in Japanese type 2 diabetic patients.
A total of 4,870 Japanese type 2 diabetic patients aged ≥20 years were divided into eight groups according to their LTPA. We investigated associations between the amount and intensity levels of physical activity (PA) and glycemic control, insulin sensitivity, cardiovascular risk factors, and low-grade systemic inflammation in a cross-sectional study.
LTPA was dose-dependently associated with body mass index (BMI), waist circumference, hemoglobin A1c (HbA1c), fasting plasma glucose, homeostasis model assessment of insulin resistance, triglyceride, high density lipoprotein cholesterol, high sensitivity C-reactive protein, and prevalence of metabolic syndrome, but not with blood pressure, low density lipoprotein cholesterol or adiponectin. The amount of PA required to lower HbA1c was greater than that required to improve cardiovascular risk factors. LTPA was inversely associated with HbA1c in non-obese participants but not in obese participants after multivariate adjustments for age, sex, duration of diabetes, current smoking, current drinking, energy intake, cardiovascular diseases, depressive symptoms, and treatment of diabetes. Higher-intensity LTPA, not lower-intensity LTPA was associated with HbA1c after multivariate adjustments with further adjustment including BMI.
Citation: Kaizu S, Kishimoto H, Iwase M, Fujii H, Ohkuma T, Ide H, et al. (2014) Impact of Leisure-Time Physical Activity on Glycemic Control and Cardiovascular Risk Factors in Japanese Patients with Type 2 Diabetes Mellitus: The Fukuoka Diabetes Registry. PLoS ONE 9(6): e98768. https://doi.org/10.1371/journal.pone.0098768
Editor: Cedric Moro, INSERM/UMR 1048, France
Received: January 9, 2014; Accepted: May 7, 2014; Published: June 4, 2014
Copyright: © 2014 Kaizu et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by JSPS KAKENHI (grant number 23249037, 23659353) for MI. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Beginning with Dr. Elliott P. Joslin in the 1920s, exercise therapy has been one of a myriad of treatments for diabetes mellitus. Until recently, however, the physiology of exercise and its clinical implications have not been well understood. The acute and chronic effects of physical activity (PA) on glycemia, insulin action, and hemodynamics have been extensively studied . In 2010, the American Diabetes Association (ADA) and American College of Sports Medicine (ACSM)  published a joint position statement titled “Exercise and type 2 diabetes” containing 295 references, of which only a few were studies from Asia, where type 2 diabetes is rapidly becoming a serious medical issue . Because large clinical trials examining exercise therapy are usually difficult to maintain because of poor adherence, a number of smaller studies have been performed and preferentially used for recent meta-analyses –. The joint position statement of the ADA and ACSM recommended 150 min per week of moderate-to-vigorous PA for type 2 diabetic patients, primarily based on prevention studies in obese patients conducted in Western countries , –. The beneficial effects of PA on glycemic control, cardiovascular risk factors, body composition, and mental health have been reported –, . However, these effects have not been confirmed in Asian diabetic patients who are typically non-obese.
Although the amount of PA is critical for determining its effectiveness on glycemic control, adherence to regular exercise is low in clinical practice. The optimal PA intensity level for the treatment of type 2 diabetes is controversial. Although high-intensity PA may lead to better glycemic control than low-intensity PA in intervention studies , type 2 diabetic patients are often unable to practice high-intensity PA because of comorbidity and aging. Therefore, observational studies in real-world settings are required to investigate the clinical usefulness of PA. In this context, we used a multicenter hospital-based database of Japanese type 2 diabetic patients in the present study. We investigated associations between the amount and intensity levels of PA and glycemic control, insulin sensitivity, cardiovascular risk factors, and low-grade systemic inflammation. As corresponding markers, we measured hemoglobin A1c (HbA1c), fasting plasma glucose, homeostasis model assessment 2 of insulin resistance (HOMA2-IR), low density lipoprotein (LDL) cholesterol, metabolic syndrome and its components, adiponectin and high sensitivity C-reactive protein (HS-CRP), which have been widely used in epidemiological studies –. We found dose-effect relationships between the amount of PA and glycemic control and cardiovascular risk factors, and that higher-intensity PA, not lower-intensity PA, was associated with glycemic control.
The Fukuoka Diabetes Registry is a multicenter prospective study designed to investigate the influence of modern treatments on the prognosis of diabetic patients regularly attending teaching hospitals certified by the Japan Diabetes Society or certified diabetologists' clinics in Fukuoka Prefecture, Japan (UMIN Clinical Trial Registry 000002627) . A total of 5,131 diabetic patients aged 20 years or older were registered between April 2008 and October 2010. Exclusion criteria were: (1) patients with drug-induced diabetes or receiving corticosteroid treatment; (2) patients undergoing renal replacement therapy; (3) patients with serious diseases other than diabetes, such as advanced malignancy or decompensated liver cirrhosis; and (4) patients unable to visit a diabetologist regularly. After excluding 261 people with type 1 diabetes, the remaining 4,870 participants were enrolled in this cross-sectional study.
This study was conducted with the approval of the Kyushu University Institutional Review Board, and written informed consent was obtained from all participants.
Assessment of PA
Using a self-administered questionnaire , the type, frequency (times per week or month), and duration (min) of leisure-time physical activity (LTPA), and the frequency (times per week) and duration (min) of walking or cycling for commuting PA were assessed. The compendium of PA was used to estimate the intensity of PA in terms of metabolic equivalents (METs) . PA was quantified as the sum of activity time (converted to hours per week) multiplied by the METs for each activity (METs·h/w), and total leisure-time physical activity (T-LTPA) was expressed as the sum of commuting PA and LTPA. Participants were divided into eight groups according to their octile of T-LTPA: −1.4 (O1), 1.5–5.6 (O2), 5.7–9.8 (O3), 9.9–13.2 (O4), 13.3–18.8 (O5), 18.9–26.5 (O6), 26.6–37.8 (O7), and 37.9–(O8) METs·h/w. Because the proportion of participants performing low-intensity PA (<3.0 METs) and high-intensity PA (≥6.0 METs) were only 6% (n = 291) and 10% (n = 457), respectively, we used 3.6 METs, the mean METs of participants, as a cut-off value for categorizing PA into lower- and higher-intensity PA.
Clinical evaluation and laboratory measurements
At baseline examinations, participants completed a self-administered questionnaire covering duration of diabetes, alcohol intake and smoking habits, energy intake, history of cardiovascular diseases, and treatment of diabetes. Alcohol intake and smoking habits were classified as either current use or not. The participants were categorized as taking oral hypoglycemic agents, insulin therapy or not. The dietary survey was conducted using a brief-type self-administered diet history questionnaire regarding food frequency of 58 items (BDHQ; Gender Medical Research Inc., Tokyo, Japan) . The presence of depressive symptoms was assessed using the Center for Epidemiologic Studies Depression Scale , and participants who scored 16 or more out of 60 points were defined as having depressive symptoms. Body weight and height were measured, body mass index (BMI) was calculated as weight (kilograms) divided by height squared (meters squared), and obesity was defined as BMI≥25 kg/m2 for Japanese people . Waist circumference at the umbilical level was measured by a trained staff member with the participant in the standing position. Blood was collected by venipuncture after an overnight fast (4,402 participants) or after breakfast (468 participants). The fed participants were excluded in statistical analyses for fasting plasma glucose, serum C peptide, HOMA2-IR, triglyceride, and metabolic syndrome. Assessments were performed at one central laboratory. HbA1c was determined using high-performance liquid chromatography (Tosoh Corp., Tokyo, Japan), plasma glucose by the glucose oxidase method, serum C-peptide by chemiluminescent immunoassay (Kyowa Medex, Tokyo, Japan), serum adiponectin and HS-CRP by latex immunonephelometry (Mitsubishi Chemical Medience, Tokyo, Japan; Siemens Healthcare Diagnostics, Tokyo, Japan), serum high density lipoprotein (HDL) cholesterol and serum LDL cholesterol by enzymatic methods (Sekisui Medical, Tokyo, Japan), and triglyceride by enzymatic methods (Shino-Test Corp., Tokyo, Japan). Insulin resistance was estimated based on fasting glucose and C-peptide concentrations using the updated homeostasis model assessment calculator provided by the Oxford Center for Diabetes Endocrinology and Metabolism  and expressed as HOMA2-IR after excluding 587 participants with unacceptable levels of fasting plasma glucose (<3.0 mmol/L or >25 mmol/L) or C-peptide (<0.2 nmol/L or >3.5 nmol/L) . Metabolic syndrome was diagnosed on the basis of the harmonized definition 2009 , i.e., the presence of at least two of the following four components: elevated waist circumference for Asians (waist circumference ≥90 cm in men and ≥80 cm in women), elevated triglyceride (≥1.68 mmol/L and/or current use of drugs for elevated triglyceride), reduced HDL cholesterol (<1.03 mmol/L for men and <1.29 mmol/L for women and/or current use of drugs for reduced HDL cholesterol), and elevated blood pressure (blood pressure ≥130/85 mmHg and/or current use of anti-hypertensive drugs).
Linear trends for age, sex, BMI, waist circumference, duration of diabetes, lifestyle and dietary factors, proportion of participants with metabolic syndrome or depressive symptoms, and treatment of diabetes across the categories of T-LTPA were tested using the Jonckheere–Terpstra test and the Cochran–Armitage test, as appropriate. Log transformations for HbA1c, triglyceride, HS-CRP and adiponectin were used to normalize skewed data, and the results were expressed as geometric means and their standard error. Age-, sex-, or multivariate-adjusted regression analyses were performed to estimate the linear association of T-LTPA, higher-intensity LTPA or lower-intensity LTPA with BMI, waist circumference, HbA1c, HOMA2-IR, triglyceride, HDL cholesterol, and HS-CRP. In the multivariate-adjusted analysis, we included age, sex, duration of diabetes, current smoking habits, current drinking habits, total energy intake, cardiovascular diseases, depressive symptoms, and treatment of diabetes (model 1). BMI was added for further adjustment (model 2). Higher-intensity LTPA was included in the multivariate-adjusted regression analysis of lower-intensity LTPA and vice versa. The correlation coefficient between higher and lower LTPA was −0.054 by Spearman's correlation analysis. For estimating the effects of the intensity of LTPA, interactions between T-LTPA and the percentage of higher-intensity LTPA per T-LTPA on BMI, waist circumstance, HbA1c, HOMA2-IR, triglyceride, HDL cholesterol, and HS-CRP were examined by adding an interaction term to the statistical model. All analyses were performed using the SAS software package version 9.3 (SAS Institute Inc., Cary, NC, USA). A P value of <0.05 was considered statistically significant in all analyses.
Table 1 shows clinical characteristics of the studied participants according to the octile of T-LTPA. As T-LTPA increased, the percentage of higher-intensity LTPA (≥3.6 METs) per T-LTPA increased. The participants were older and less obese with an increase in T-LTPA. The proportions of male participants and duration of diabetes, current drinkers and dietary energy intake increased, whereas BMI, waist circumstance, the proportions of current smokers, and participants with cardiovascular disease or depressive symptoms decreased. Although the proportion of participants treated with oral hypoglycemic agents did not differ among groups, the proportion of those using insulin reduced as T-LTPA increased.
As shown in Figures 1 and 2, age- and sex-adjusted BMI, waist circumference, HbA1c, fasting plasma glucose, HOMA2-IR, triglyceride, HS-CRP and prevalence of metabolic syndrome decreased dose-dependently as T-LTPA increased (p for trend all <0.001 for BMI, waist circumference, HbA1c, fasting plasma glucose, HOMA2-IR, triglyceride, HS-CRP, and prevalence of metabolic syndrome). Age- and sex-adjusted HDL cholesterol increased dose-dependently with T-LTPA (p for trend <0.001). Compared with the lowest category O1, the difference became statistically significant at O3 for BMI, waist circumference, and HS-CRP, at O4 for HOMA2-IR, HDL cholesterol, and prevalence of metabolic syndrome, at O5 for triglyceride, and at O6 for HbA1c. Systolic blood pressure, LDL cholesterol, and serum adiponectin did not show a linear trend across octiles of T-LTPA.
Age- and sex-adjusted body mass index (BMI) (A), waist circumference (B), hemoglobin A1c (HbA1c) (C), fasting plasma glucose (D), homeostasis model assessment 2 of insulin resistance (HOMA2-IR) (E), and adiponectin (F) in the octile of T-LTPA in 4,870 Japanese type 2 diabetic patients. +p<0.05, *p<0.01 vs. the lowest O1.
Age- and sex-adjusted triglyceride (A), high density lipoprotein (HDL) cholesterol (B), low density lipoprotein (LDL) cholesterol (C), systolic blood pressure (D), high sensitivity C-reactive protein (HS-CRP) (E), and prevalence of metabolic syndrome (F) in the octile of T-LTPA in 4,870 Japanese type 2 diabetic patients. +p<0.05, *p<0.01 vs. the lowest O1.
Table 2 shows the results of multiple regression analysis of T-LTPA with metabolic and inflammatory variables in non-obese and obese participants. Waist circumference, HOMA2-IR, triglyceride, HDL cholesterol, and HS-CRP significantly correlated with T-LTPA in both non-obese and obese participants after multivariate adjustments for age, sex, duration of diabetes, current smoking, current drinking, energy intake, cardiovascular diseases, depressive symptoms, and treatment of diabetes. Conversely, T-LTPA significantly correlated with HbA1c in non-obese participants but not in obese participants.
Table 3 shows the results of multiple regression analysis of lower- or higher-intensity LTPA with metabolic and inflammatory variables. BMI and waist circumference negatively correlated with both lower- and higher-intensity LTPA after multivariate adjustments for age, sex, duration of diabetes, current smoking, current drinking, energy intake, cardiovascular diseases, depressive symptoms, treatment of diabetes, and higher (lower)-intensity LTPA. After further adjustment with BMI, waist circumference negatively correlated with higher-intensity LTPA but not with lower-intensity LTPA. HbA1c and HOMA2-IR significantly correlated with only higher-intensity LTPA. These associations with higher-intensity LTPA remained significant after further adjustment with BMI. Triglyceride, HDL cholesterol, and HS-CRP significantly correlated with both lower- and higher-intensity LTPA after multivariate adjustments. These associations remained significant after further adjustment with BMI, except the association between HS-CRP and lower-intensity LTPA (p = 0.054). Furthermore, we analyzed the effects of the interaction between T-LTPA and the percentage of higher-intensity LTPA per T-LTPA and found that intensity differences were statistically significant for HbA1c and HOMA2-IR (Pinteraction: 0.04 and 0.02, respectively), but not for waist circumference, triglyceride, HDL cholesterol, or HS-CRP (Pinteraction: 0.12, 0.93, 0.77, and 0.77, respectively).
The present study demonstrated that: (1) T-LTPA was dose-dependently associated with BMI, waist circumference, HbA1c, fasting plasma glucose, HOMA2-IR, triglyceride, HDL cholesterol, HS-CRP, and prevalence of metabolic syndrome; (2) T-LTPA was inversely associated with HbA1c in non-obese participants but not in obese participants after multivariate adjustment; (3) higher-intensity LTPA (≥3.6 METs) was associated with HbA1c and HOMA2-IR, whereas lower-intensity LTPA was not. Although there are many intervention trials using exercise at mostly moderate-to-high intensity PA in diabetic patients, epidemiological evidence regarding exercise as a treatment modality in real-world settings is scarce in Asian type 2 diabetic patients to the best of the authors' knowledge –.
In the present study, the amounts of T-LTPA from which clinical variables significantly improved as compared with O1 (mean: 0.1 METs·h/w) were O3 (mean: 7.7 METs·h/w) for BMI, waist circumference, and HS-CRP, O4 (mean: 11.9 METs·h/w) for HOMA2-IR, HDL cholesterol, and prevalence of metabolic syndrome, and O5 (mean: 15.9 METs·h/w) for triglyceride and O6 (mean: 23.1 METs·h/w) for HbA1c, respectively. The amount recommended by the joint position statement of the ADA and ACSM in type 2 diabetic patients is 150 min/w of aerobic exercise of moderate-to-vigorous intensity . When moderate intensity, defined as 3–6 METs (mean: 4.5 METs), is used, the recommended amount is converted into 7.5–15.0 METs·h/w (mean: 11.3 METs·h/w), corresponding to O3–O5 (O4) in our study. In addition, the joint position statement suggested that exercise may result in a small reduction in LDL cholesterol with no change in triglyceride or HDL cholesterol and slightly lower systolic blood pressure . In the present study, however, LDL cholesterol or blood pressure did not differ according to T-LTPA, whereas triglyceride and HDL cholesterol dose-dependently improved. Dose-effect relationships between PA and clinical variables have been reported by Di Loreto et al.  who studied the effect of different amounts of increased PA in 179 type 2 diabetic patients. HbA1c, triglyceride, and blood pressure improved from the group mean of 17.1 METs·h/w and body weight, waist circumference, HDL cholesterol, and LDL cholesterol improved from the group mean of 27.0 METs·h/w. In the Italian Diabetes and Exercise Study, however, no clear dose-dependent effects except for BMI and waist circumference were observed . In a recent meta-analysis , the mean decline in HbA1c with structured exercise training was 0.67% (7.3 mmol/mol), whereas the difference in HbA1c between O1 and O8 in our study was only 0.2% (2.2 mmol/mol). These conflicting results may be explained by differences in study design (intervention vs. observational study), methods in assessing PA, ethnicity  and so on.
Although exercise is a cornerstone of treatment in type 2 diabetic patients, its effect on glycemic control and cardiovascular risk factors has not been confirmed in Asians, who are typically non-obese. In this Japanese study (mean BMI: 23.8 kg/m2), increased T-LTPA was associated with improvement in glycemic control and cardiovascular risk factors, except for blood pressure and LDL cholesterol. When stratified by the presence of obesity, T-LTPA was not significantly associated with HbA1c in obese participants after multivariate adjustment (Table 2). This is in contrast with a prevention study of Korean people (mean BMI: 25.0 kg/m2), which showed that regular exercise (300 min/w) of moderate-intensity prevented the development of type 2 diabetes in those with BMI≥25 kg/m2 but not with BMI<25.0 kg/m2 . The disagreement may be because of differences in the study designs, i.e., observational vs. intervention study. In addition, the lack of an association between HbA1c and T-LTPA seen in obese participants may be because of the smaller amounts of T-LTPA, especially higher-intensity LTPA, in obese participants compared with non-obese participants (T-LTPA: 15.7±18.0 METs·h/w vs. 20.3±19.3 METs·h/w, p<0.001; higher-intensity LTPA: 9.2±13.7 METs·h/w vs. 12.9±15.8 METs·h/w, p<0.001). As shown in Table 3, higher-intensity LTPA was associated with HbA1c independent of BMI, but lower-intensity LTPA was not. The relationship between training intensity and improvement in glycemic control has been controversial. Umpierre et al.  reported that the frequency of aerobic exercise was associated with the reduction in HbA1c, but the intensity showed no significant association with changes in HbA1c by meta-regression analysis of randomized clinical trials. In the Italian Diabetes and Exercise Study, the exercise effect on glycemic control and cardiovascular risk factors was prospectively compared between low-to-moderate and moderate-to-high intensity under similar amounts of total PA for 12 months . Balducci et al.  reported that supervised moderate-to-high intensity exercise was marginally but significantly associated with better HbA1c, triglyceride, and total cholesterol levels. In the present study, the interaction between T-LTPA and the percentage of higher-intensity LTPA per T-LTPA was significant on HbA1c and HOMA2-IR, suggesting the role of the intensity of PA in the regulation of glycemia and insulin action, at least in Japanese type 2 diabetic patients who are leaner than Western patients.
We found that the mean intensity of LTPA was 3.6 METs, the proportion of participants with low-intensity LTPA (<3.0 METs) was 6.0%, and the proportion of those with vigorous-intensity LTPA (≥6.0 METs) was 10.2% in type 2 diabetic patients attending diabetes special clinics in Japan. Therefore, most participants were considered to practice moderate-intensity LTPA (3.0–6.0 METs) as their non-pharmacological treatment. However, the amount of slightly lower-intensity LTPA (3.0–3.6 METs) was not associated with HbA1c or HOMA2-IR by multiple regression analysis (data not shown), whereas the amount of slightly higher-intensity LTPA (3.6–6.0 METs) was significantly associated with them (HbA1c: β = −0.0004, p = 0.01 in model 2+lower-intensity LTPA; β = −0.0003, p = 0.03 in model 2+lower-intensity LTPA+BMI; HOMA2-IR: β = −0.0033, p<0.001 in model 2+lower-intensity LTPA; β = −0.0018, p = 0.001 in model 2+lower-intensity LTPA+BMI). These findings suggest that higher-intensity PA (for example, brisk walking, METs 3.8) may be required to improve glycemic control even in the range of moderate intensity (3.0–6.0 METs) of PA.
The anti-inflammatory effect of PA has been demonstrated in exercise intervention studies in type 2 diabetic patients . The mechanisms behind the suppression of HS-CRP by PA may include: (1) the amelioration of insulin resistance induced by an exercise intensity-dependent release of interleukin-6 from muscle fibers ; and (2) enhanced expression of adiponectin receptor, despite unchanged serum adiponectin levels . Chronic low-grade inflammation reflects the state of enhanced oxidative stress and insulin resistance, which may contribute to the development and progression of diabetic complications. Measures leading to a reduction in HS-CRP may be beneficial in preventing diabetic complications. Recently, Kodama et al.  reported that the risks of all-cause mortality and cardiovascular disease were exponentially suppressed with increasing habitual PA by a meta-analysis of cohort studies without exercise intervention. All-cause mortality and cardiovascular disease were reduced with medium amounts of LTPA (8.3 METs·h/w) corresponding to our O3 by 11.2% and 9.3%, respectively, and at high amounts of LTPA (16.7 METs·h/w) corresponding to our O5 by 21.2% and 17.9%, respectively. The present study showed that the amount of T-LTPA required to reduce HS-CRP was lower than that required to reduce HbA1c (O3 vs. O6).
The strengths of the study are: (1) the sample size is relatively large (n = 4,870); (2) PA is quantified using a universal MET score in real-world settings ; and (3) confounding factors include dietary data and depressive symptoms. The limitations of the study are: (1) we did not measure occupational PA, although most participants seemed to have retired from work because their mean age was 65 years. We performed stratified analysis between ≥65 and <65 years of age, and the association between T-LTPA and glycemic control and CVD risk factors did not differ in those of ≥65 and <65 years of age (interaction p for the age of 65 years and T-LTPA in the age- and sex-adjusted model was 0.167 for BMI, 0.947 for waist circumference, 0.070 for HbA1c, 0.420 for HOMA2-IR, 0.832 for triglyceride, 0.315 for HDL cholesterol and 0.704 for HS-CRP, respectively); (2) practising PA may have been restricted because of medical reasons, such as severe retinopathy or arthritis. Although physical fitness was not assessed during recruitment for the study, participants seemed to be active enough to be able to attend the out-patient department regularly; (3) PA was assessed using a self-reported questionnaire, which may have resulted in an overestimation. In addition, participants may be physically less active in the winter time. However, the time of year did not significantly affect the T-LTPA because of the warm climate of our prefecture (18.1±17.7 METs·h/w in the spring, 18.5±19.5 METs·h/w in the summer, 19.6±18.7 METs·h/w in the fall, 20.2±20.8 METs·h/w in the winter, ns); (4) we cannot show any cause-and-effect relationships because of the cross-sectional design of our study; and (5) there may be other confounding factors besides those evaluated.
In conclusion, we demonstrated clear dose-dependent relationships between T-LTPA and glycemic control and some cardiovascular risk factors in Japanese type 2 diabetic patients. However, the amount of T-LTPA required to lower HbA1c appeared to be greater than that required to improve other cardiovascular risk factors in our cohort. In addition, higher-intensity LTPA may be more appropriate even in the range of moderate-intensity PA recommended for diabetes treatment. From the results of this study, it is suggested that brisk walking more than 2 hours a week may improve the health of Japanese type 2 diabetic patients. Although increased PA may be an effective treatment in Japanese type 2 diabetic patients as well as in Western patients, there may be some ethnic differences between them.
We thank Drs. Yutaka Kiyohara, Yasufumi Doi, Shigenobu Kanba, Dongchon Kang, Shuzo Kumagai (Kyushu University), Tomoko Shirota, Hiroyuki Imamura, Reika Oshikata (Nakamura Gakuen University), Nobutaka Tsutsu, Nobuhiro Sasaki, Sakae Nohara, Chie Miyagawa, Yuji Komorida (Fukuoka Red Cross Hospital), Kiyohide Nunoi, Yuichi Sato, Hirofumi Imoto, Masae Toyonaga, Ayumi Yamauchi, Chisa Matsumoto (St. Mary's Hospital), Kazushi Amano, Kaori Itoh (Steel Memorial Yawata Hospital), Daisuke Gotoh, Toshitaka Himeno, Chie Sejima (Kyushu Central Hospital), Noriyasu Shinohara, Ayako Tsutsumi, Akiko Sumi (Fukuoka Higashi Medical Center), Masahiro Nakano, Mina Matsuo, Shoko Morimoto, Tomoko Hyodo (Hakujyuji Hospital), Masae Minami (Clinic Minami Masae), Miya Wada (Wada Miya Naika Clinic), Yoshifumi Yokomizo (Yokomizo Naika Clinic), Masanori Kikuchi (Kikuchi Naika Clinic), Riku Nomiyama (Suzuki Naika Clinic), Shin Nakamura (Nakamura Naika Clinic), Kenji Tashiro (Oshima Eye Hospital), Mototaka Yoshinari (Yoshinari Naika Clinic), Kojiro Ichikawa (Fukutsu Naika Clinic), and Teruo Omae (Hisayama Research Institute For Lifestyle Diseases), clinical research coordinators; Chiho Ohba, Yumi Ono (Hisayama Research Institute For Lifestyle Diseases), Kayoko Sekioka (Kyushu University), and administration office; Tomoko Matake (Hisayama Research Institute For Lifestyle Diseases), Junko Ishimatsu (Kyushu University).
Conceived and designed the experiments: SK HF MI. Performed the experiments: SK MI. Analyzed the data: SK MI. Wrote the paper: SK MI. Helped to interpret the data: HK HF TO HI YK YI TJ YH UN TK. Contributed to the discussion: HK HF TO HI YK YI TJ YH UN TK. Critically revised the manuscript: SK HK HF MI TO HI YK YI TJ YH UN TK. Approved the final version: SK HK HF MI TO HI YK YI TJ YH UN TK.
- 1. Colberg SR, Sigal RJ, Fernhall B, Regensteiner JG, Blissmer BJ, et al. (2010) Exercise and type 2 diabetes: the American College of Sports Medicine and the American Diabetes Association: joint position statement. Diabetes Care 33: e147–167.
- 2. Chan JC, Malik V, Jia W, Kadowaki T, Yajnik CS, et al. (2009) Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA 301: 2129–2140.
- 3. Kodama S, Tanaka S, Heianza Y, Fujihara K, Horikawa C, et al. (2013) Association between physical activity and risk of all-cause mortality and cardiovascular disease in patients with diabetes: a meta-analysis. Diabetes Care 36: 471–479.
- 4. Umpierre D, Ribeiro PA, Schaan BD, Ribeiro JP (2013) Volume of supervised exercise training impacts glycaemic control in patients with type 2 diabetes: a systematic review with meta-regression analysis. Diabetologia 56: 242–251.
- 5. Pattyn N, Cornelissen VA, Eshghi SR, Vanhees L (2013) The effect of exercise on the cardiovascular risk factors constituting the metabolic syndrome: a meta-analysis of controlled trials. Sports Med 43: 121–133.
- 6. van der Heijden MM, van Dooren FE, Pop VJ, Pouwer F (2013) Effects of exercise training on quality of life, symptoms of depression, symptoms of anxiety and emotional well-being in type 2 diabetes mellitus: a systematic review. Diabetologia 56: 1210–1225.
- 7. Hayashino Y, Jackson JL, Fukumori N, Nakamura F, Fukuhara S (2012) Effects of supervised exercise on lipid profiles and blood pressure control in people with type 2 diabetes mellitus: a meta-analysis of randomized controlled trials. Diabetes Res Clin Pract 98: 349–360.
- 8. Chudyk A, Petrella RJ (2011) Effects of exercise on cardiovascular risk factors in type 2 diabetes: a meta-analysis. Diabetes Care 34: 1228–1237.
- 9. Umpierre D, Ribeiro PA, Kramer CK, Leitao CB, Zucatti AT, et al. (2011) Physical activity advice only or structured exercise training and association with HbA1c levels in type 2 diabetes: a systematic review and meta-analysis. JAMA 305: 1790–1799.
- 10. United States Department of Health and Human Services (2008) Physical activity guidelines for Americans. Available: http://www.health.gov/PAGuidelines/guidelines/default.aspx. Accessed 2013 Oct 30.
- 11. Jeon CY, Lokken RP, Hu FB, van Dam RM (2007) Physical activity of moderate intensity and risk of type 2 diabetes: a systematic review. Diabetes Care 30: 744–752.
- 12. O'Hagan C, De Vito G, Boreham CA (2013) Exercise prescription in the treatment of type 2 diabetes mellitus: current practices, existing guidelines and future directions. Sports Med 43: 39–49.
- 13. Boule NG, Kenny GP, Haddad E, Wells GA, Sigal RJ (2003) Meta-analysis of the effect of structured exercise training on cardiorespiratory fitness in Type 2 diabetes mellitus. Diabetologia 46: 1071–1081.
- 14. Dominguez CS, Cabrera de LA, Rodriguez PMC, Borges AC, Carrillo FL, et al. (2010) Association between glycemic index, glycemic load, and fructose with insulin resistance: the CDC of the Canary Islands study. Eur J Nutr 49: 505–512.
- 15. Nakamura Y, Sekikawa A, Kadowaki T, Kadota A, Kadowaki S, et al. (2009) Visceral and subcutaneous adiposity and adiponectin in middle-aged Japanese men: the ERA JUMP study. Obesity 17: 1269–1273.
- 16. Ridker PM (2001) High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation 103: 1813–1818.
- 17. Ohkuma T, Fujii H, Iwase M, Kikuchi Y, Ogata S, et al. (2013) Impact of eating rate on obesity and cardiovascular risk factors according to glucose tolerance status: the Fukuoka Diabetes Registry and the Hisayama Study. Diabetologia 56: 70–77.
- 18. Ishikawa-Takata K, Naito Y, Tanaka S, Ebine N, Tabata I (2011) Use of doubly labeled water to validate a physical activity questionnaire developed for the Japanese population. J Epidemiol 21: 114–121.
- 19. Ainsworth BE, Haskell WL, Whitt MC, Irwin ML, Swartz AM, et al. (2000) Compendium of physical activities: an update of activity codes and MET intensities. Med Sci Sports Exerc 32: S498–504.
- 20. Kobayashi S, Murakami K, Sasaki S, Okubo H, Hirota N, et al. (2011) Comparison of relative validity of food group intakes estimated by comprehensive and brief-type self-administered diet history questionnaires against 16 d dietary records in Japanese adults. Public Health Nutr 14: 1200–1211.
- 21. Radloff LS (1977) The CES-D Scale: A self-report depression scale for research in the general population. Appl Psychol Meas 1: 385–401.
- 22. The Examination Committee of Criteria for ‘Obesity Disease’ in Japan, Japan Society for the Study of Obesity (2002) New criteria for ‘obesity disease’ in Japan. Circ J 66: 987–992.
- 23. Homa calculator. Available: http://www.Dtu.Ox.Ac.Uk/homacalculator/index.Php Accessed 2013 Oct 30.
- 24. Wallace TM, Levy JC, Matthews DR (2004) Use and abuse of HOMA modeling. Diabetes Care 27: 1487–1495.
- 25. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, et al. (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120: 1640–1645.
- 26. Iijima K, Iimuro S, Shinozaki T, Ohashi Y, Sakurai T, et al. (2012) Lower physical activity is a strong predictor of cardiovascular events in elderly patients with type 2 diabetes mellitus beyond traditional risk factors: the Japanese Elderly Diabetes Intervention Trial. Geriatr Gerontol Int 12 Suppl 177–87.
- 27. Li CL, Chang HY, Hsu CC, Lu JF, Fang HL (2013) Joint predictability of health related quality of life and leisure time physical activity on mortality risk in people with diabetes. BMC Public Health 13: 67.
- 28. Sone H, Tanaka S, Suzuki S, Seino H, Hanyu O, et al. (2013) Leisure-time physical activity is a significant predictor of stroke and total mortality in Japanese patients with type 2 diabetes: analysis from the Japan Diabetes Complications Study (JDCS). Diabetologia 56: 1021–1030.
- 29. Di Loreto C, Fanelli C, Lucidi P, Murdolo G, De Cicco A, et al. (2005) Make your diabetic patients walk: long-term impact of different amounts of physical activity on type 2 diabetes. Diabetes Care 28: 1295–1302.
- 30. Balducci S, Zanuso S, Nicolucci A, De Feo P, Cavallo S, et al. (2010) Effect of an intensive exercise intervention strategy on modifiable cardiovascular risk factors in subjects with type 2 diabetes mellitus: a randomized controlled trial: the Italian Diabetes and Exercise Study (IDES). Arch Intern Med 170: 1794–1803.
- 31. Sukala WR, Page R, Cheema BS (2012) Exercise training in high-risk ethnic populations with type 2 diabetes: a systematic review of clinical trials. Diabetes Res Clin Pract 97: 206–216.
- 32. Chae JS, Kang R, Kwak JH, Paik JK, Kim OY, et al. (2012) Supervised exercise program, BMI, and risk of type 2 diabetes in subjects with normal or impaired fasting glucose. Diabetes Care 35: 1680–1685.
- 33. Balducci S, Zanuso S, Cardelli P, Salvi L, Bazuro A, et al. (2012) Effect of high- versus low-intensity supervised aerobic and resistance training on modifiable cardiovascular risk factors in type 2 diabetes; the Italian Diabetes and Exercise Study (IDES). PLoS One 7: e49297.
- 34. Beavers KM, Brinkley TE, Nicklas BJ (2010) Effect of exercise training on chronic inflammation. Clin Chim Acta 411: 785–793.
- 35. Pedersen BK, Febbraio MA (2008) Muscle as an endocrine organ: focus on muscle-derived interleukin-6. Physiol Rev 88: 1379–1406.
- 36. O'Leary VB, Jorett AE, Marchetti CM, Gonzalez F, Phillips SA, et al. (2007) Enhanced adiponectin multimer ratio and skeletal muscle adiponectin receptor expression following exercise training and diet in older insulin-resistant adults. Am J Physiol Endocrinol Metab 293: E421–427.